Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000973

Drug Information
SynonymsAC1MHW5N; 1-(3,4-dihydro-2H-chromen-2-yl)-N-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine; CID3058747; L001578; UNII-467LU0UCUW; Sarizotan; N-((3,4-Dihydro-2H-1-benzopyran-2-yl)methyl)-5-(4-fluorophenyl)-3-pyridinemethanamine; EMD 128130; 177975-08-5; (-)-3-((((R)-2-Chromanylmethyl)amino)methyl)-5-(p-fluorophenyl)pyridine; Sarizotan [INN]; LS-192590
CompanyEMD Serono
IndicationParkinsoní»s Disease
[ICD9: 332   ICD10: F02.3, G20]
Discontinued in Phase II    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1CC2=CC=CC=C2OC1CNCC3=CN=CC(=C3)C4=CC=C(C=C4)F    
CAS NumberCAS 177976-12-4
PubChem Compound IDCID 3058747.
PubChem Substance IDSID 3862729.
Target5-hydroxytryptamine receptor 1AAgonist[1]
5-hydroxytryptamine receptor 1AMultitarget[1]
D(3) dopamine receptorAgonist[1]
D(3) dopamine receptorMultitarget[1]
D(4) dopamine receptorAgonist[1]
D(4) dopamine receptorMultitarget[1]
Ref 1Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543